摘要:
The invention relates to isolated populations of CD4 + GPA33 high regulatory T cells, to methods for detecting and/or isolating CD4 + GPA33 high cells, methods for enriching for CD4 + GPA33 high cells and to uses of CD4 + GPA33 high cells and populations of such cells. The invention further relates to methods for classifying an individual suffering from cancer and typing a tumor sample as well as for determining the etiology of autoimmune diseases.
摘要:
Disclosed is a new method of treatment of cancer. Inhibition of the MAP3K1-MAP2K4-JNK pathway, and/or inhibitions of various RTK,and inhibition of the MEK-ERK pathway was found to be useful in the treatment of various cancers, including cancers harboring a KRAS mutation. The treatment is in particular useful in patients harboring wild-type MAP2K4 and MAP3K1 and not responding to inhibitors of the MEK-ERK pathway, in particular MEK inhibitors.
摘要:
The invention relates to amagnetic marker for use in locating tissue for surgery, comprisinga casing, andtwo to five magnetic elements arranged in a row. The two or more magnetic elements are separated from each other by an isolating material. The magnetic marker may be non-bio-absorbable. This means that the magnetic marker is invariable as it does not decay over time. This invariability ensures that on the basis of the signal measured by a magnetometer devicea distance between a probe of the magnetometer deviceand the magnetic marker can be determined.
摘要:
The present invention concerns compounds that are capable of covalently entrapping adenylatingenzymes. The present inventionis essentially based on the discovery that analogues of adenylating enzyme (AE) substrates, wherein a methylene group has been incorporated at the carbon atom in the α-position relative to the carboxylate group involved in the adenylation, are capable of undergoing the adenylation reaction, thereby creating an activated methylene group in situ. The resulting 'armed' acyladenylate can interact with the enzyme resulting in covalent entrapment. Interestingly, the acyladenylate can alternatively be transferredto the next step in the enzyme cascade, followingwhich the activated methylene group can interact with thenext(active site cysteine containing) enzyme in theenzymatic cascade. The AE substrate analogues, based on their capability of 'entrapping' the respective enzymes, will have utility as activity based probes in biological research and also as diagnostic and/or therapeutic agents.
摘要:
The invention relates to a method of predicting whether a breast cancer patient is or becomes resistant to anti-estrogen directed therapy. More specifically, the invention relates to methods and means for typing of breast cancer cells as having a good or a poor outcome to anti-estrogen directed therapy. The invention further relates to methods of assigning therapy to a breast cancer patient.
摘要:
The present invention is in the field of triacylglycerol synthesis. In particular the invention relates to the identification of DIESL as a new triacylglycerol synthase. The invention also relates to the identification of TMX1 as a negative regulator of DIESL mediated triacylglycerol synthesis. Screening assays for identifying agents that modulate the activity of DIESL and/or of TMX1, or that modulate the interaction between DIESL and TMX1 are also provided.
摘要:
Generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
摘要:
A monitoring device for monitoring a hypocortiolism patient, the monitoring device comprising: - a needle for penetrating a skin of the patient, and - an analysis module fluidly connected with the needle, the analysis module comprising: o a first sensor, for measuring an inflammation level representative for the patient; and/or o a second sensor, for measuring a stress level representative for the patient; and wherein the monitoring device is configured to automatically trigger a notification in response to the first sensor measuring an inflammation level exceeding a first pre-defined threshold and/or in response to the second sensor measuring a stress level exceeding a second pre-defined threshold.
摘要:
The invention relates to methods for tumor marker analysis comprising providing a genomic DNA sample from tumor cells of a patient, preselecting a chromosomal region on the genomic DNA comprising at least part of a potential structural variant (SV); and sequencing the genomic region to characterize the potential SV. The invention further relates to methods for detecting minimal residual disease, monitoring treatment response and tumor progression in a patient by employing the SV, and to personalized therapy based on the identity of the SV.